Global and United States Parkinson's Disease (PD) Drugs Market Report & Forecast 2024-2031

Report ID: 1860335 | Published Date: Sep 2024 | No. of Page: 111 | Base Year: 2023 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Parkinson's Disease (PD) Drugs Product Introduction
    1.2 Global Parkinson's Disease (PD) Drugs Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Parkinson's Disease (PD) Drugs Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Parkinson's Disease (PD) Drugs Sales in Volume for the Year 2017-2028
    1.3 United States Parkinson's Disease (PD) Drugs Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Parkinson's Disease (PD) Drugs Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Parkinson's Disease (PD) Drugs Sales in Volume for the Year 2017-2028
    1.4 Parkinson's Disease (PD) Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Parkinson's Disease (PD) Drugs in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Parkinson's Disease (PD) Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Parkinson's Disease (PD) Drugs Market Dynamics
        1.5.1 Parkinson's Disease (PD) Drugs Industry Trends
        1.5.2 Parkinson's Disease (PD) Drugs Market Drivers
        1.5.3 Parkinson's Disease (PD) Drugs Market Challenges
        1.5.4 Parkinson's Disease (PD) Drugs Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Parkinson's Disease (PD) Drugs Market Segment by Type
        2.1.1 Dopamine Agonist
        2.1.2 Monoamine Oxidase Inhibitors
        2.1.3 Acetylcholinesterase Inhibitors
        2.1.4 Glutamate Inhibitors
    2.2 Global Parkinson's Disease (PD) Drugs Market Size by Type
        2.2.1 Global Parkinson's Disease (PD) Drugs Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Parkinson's Disease (PD) Drugs Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Parkinson's Disease (PD) Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Parkinson's Disease (PD) Drugs Market Size by Type
        2.3.1 United States Parkinson's Disease (PD) Drugs Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Parkinson's Disease (PD) Drugs Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Parkinson's Disease (PD) Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Parkinson's Disease (PD) Drugs Market Segment by Application
        3.1.1 Hospital
        3.1.2 Family
    3.2 Global Parkinson's Disease (PD) Drugs Market Size by Application
        3.2.1 Global Parkinson's Disease (PD) Drugs Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Parkinson's Disease (PD) Drugs Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Parkinson's Disease (PD) Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Parkinson's Disease (PD) Drugs Market Size by Application
        3.3.1 United States Parkinson's Disease (PD) Drugs Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Parkinson's Disease (PD) Drugs Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Parkinson's Disease (PD) Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Parkinson's Disease (PD) Drugs Competitor Landscape by Company
    4.1 Global Parkinson's Disease (PD) Drugs Market Size by Company
        4.1.1 Top Global Parkinson's Disease (PD) Drugs Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Parkinson's Disease (PD) Drugs Revenue by Manufacturer (2017-2022)
        4.1.3 Global Parkinson's Disease (PD) Drugs Sales by Manufacturer (2017-2022)
        4.1.4 Global Parkinson's Disease (PD) Drugs Price by Manufacturer (2017-2022)
    4.2 Global Parkinson's Disease (PD) Drugs Concentration Ratio (CR)
        4.2.1 Parkinson's Disease (PD) Drugs Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Parkinson's Disease (PD) Drugs in 2021
        4.2.3 Global Parkinson's Disease (PD) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Parkinson's Disease (PD) Drugs Manufacturing Base Distribution, Product Type
        4.3.1 Global Parkinson's Disease (PD) Drugs Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Parkinson's Disease (PD) Drugs Product Type
        4.3.3 Date of International Manufacturers Enter into Parkinson's Disease (PD) Drugs Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Parkinson's Disease (PD) Drugs Market Size by Company
        4.5.1 Top Parkinson's Disease (PD) Drugs Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Parkinson's Disease (PD) Drugs Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Parkinson's Disease (PD) Drugs Sales by Players (2020, 2021 & 2022)
5 Global Parkinson's Disease (PD) Drugs Market Size by Region
    5.1 Global Parkinson's Disease (PD) Drugs Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Parkinson's Disease (PD) Drugs Market Size in Volume by Region (2017-2028)
        5.2.1 Global Parkinson's Disease (PD) Drugs Sales in Volume by Region: 2017-2022
        5.2.2 Global Parkinson's Disease (PD) Drugs Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Parkinson's Disease (PD) Drugs Market Size in Value by Region (2017-2028)
        5.3.1 Global Parkinson's Disease (PD) Drugs Sales in Value by Region: 2017-2022
        5.3.2 Global Parkinson's Disease (PD) Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Parkinson's Disease (PD) Drugs Market Size YoY Growth 2017-2028
        6.1.2 North America Parkinson's Disease (PD) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Parkinson's Disease (PD) Drugs Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Parkinson's Disease (PD) Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Parkinson's Disease (PD) Drugs Market Size YoY Growth 2017-2028
        6.3.2 Europe Parkinson's Disease (PD) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Parkinson's Disease (PD) Drugs Market Size YoY Growth 2017-2028
        6.4.2 Latin America Parkinson's Disease (PD) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Parkinson's Disease (PD) Drugs Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Parkinson's Disease (PD) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 Boehringer Ingelheim
        7.1.1 Boehringer Ingelheim Corporation Information
        7.1.2 Boehringer Ingelheim Description and Business Overview
        7.1.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Products Offered
        7.1.5 Boehringer Ingelheim Recent Development
    7.2 GlaxoSmithKline
        7.2.1 GlaxoSmithKline Corporation Information
        7.2.2 GlaxoSmithKline Description and Business Overview
        7.2.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 GlaxoSmithKline Parkinson's Disease (PD) Drugs Products Offered
        7.2.5 GlaxoSmithKline Recent Development
    7.3 Novartis
        7.3.1 Novartis Corporation Information
        7.3.2 Novartis Description and Business Overview
        7.3.3 Novartis Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Novartis Parkinson's Disease (PD) Drugs Products Offered
        7.3.5 Novartis Recent Development
    7.4 Teva Pharmaceutical Industries
        7.4.1 Teva Pharmaceutical Industries Corporation Information
        7.4.2 Teva Pharmaceutical Industries Description and Business Overview
        7.4.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Products Offered
        7.4.5 Teva Pharmaceutical Industries Recent Development
    7.5 AbbVie
        7.5.1 AbbVie Corporation Information
        7.5.2 AbbVie Description and Business Overview
        7.5.3 AbbVie Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 AbbVie Parkinson's Disease (PD) Drugs Products Offered
        7.5.5 AbbVie Recent Development
    7.6 Abital Pharma
        7.6.1 Abital Pharma Corporation Information
        7.6.2 Abital Pharma Description and Business Overview
        7.6.3 Abital Pharma Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Abital Pharma Parkinson's Disease (PD) Drugs Products Offered
        7.6.5 Abital Pharma Recent Development
    7.7 Addex Therapeutics
        7.7.1 Addex Therapeutics Corporation Information
        7.7.2 Addex Therapeutics Description and Business Overview
        7.7.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Addex Therapeutics Parkinson's Disease (PD) Drugs Products Offered
        7.7.5 Addex Therapeutics Recent Development
    7.8 Biogen
        7.8.1 Biogen Corporation Information
        7.8.2 Biogen Description and Business Overview
        7.8.3 Biogen Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 Biogen Parkinson's Disease (PD) Drugs Products Offered
        7.8.5 Biogen Recent Development
    7.9 Eisai
        7.9.1 Eisai Corporation Information
        7.9.2 Eisai Description and Business Overview
        7.9.3 Eisai Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.9.4 Eisai Parkinson's Disease (PD) Drugs Products Offered
        7.9.5 Eisai Recent Development
    7.10 Eli Lilly
        7.10.1 Eli Lilly Corporation Information
        7.10.2 Eli Lilly Description and Business Overview
        7.10.3 Eli Lilly Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.10.4 Eli Lilly Parkinson's Disease (PD) Drugs Products Offered
        7.10.5 Eli Lilly Recent Development
    7.11 F. Hoffmann-La Roche
        7.11.1 F. Hoffmann-La Roche Corporation Information
        7.11.2 F. Hoffmann-La Roche Description and Business Overview
        7.11.3 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.11.4 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Products Offered
        7.11.5 F. Hoffmann-La Roche Recent Development
    7.12 H. Lundbeck
        7.12.1 H. Lundbeck Corporation Information
        7.12.2 H. Lundbeck Description and Business Overview
        7.12.3 H. Lundbeck Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.12.4 H. Lundbeck Products Offered
        7.12.5 H. Lundbeck Recent Development
    7.13 Impax Laboratories
        7.13.1 Impax Laboratories Corporation Information
        7.13.2 Impax Laboratories Description and Business Overview
        7.13.3 Impax Laboratories Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.13.4 Impax Laboratories Products Offered
        7.13.5 Impax Laboratories Recent Development
    7.14 Kyowa Hakko Kirin
        7.14.1 Kyowa Hakko Kirin Corporation Information
        7.14.2 Kyowa Hakko Kirin Description and Business Overview
        7.14.3 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.14.4 Kyowa Hakko Kirin Products Offered
        7.14.5 Kyowa Hakko Kirin Recent Development
    7.15 Otsuka Pharmaceutical
        7.15.1 Otsuka Pharmaceutical Corporation Information
        7.15.2 Otsuka Pharmaceutical Description and Business Overview
        7.15.3 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.15.4 Otsuka Pharmaceutical Products Offered
        7.15.5 Otsuka Pharmaceutical Recent Development
    7.16 Pfizer
        7.16.1 Pfizer Corporation Information
        7.16.2 Pfizer Description and Business Overview
        7.16.3 Pfizer Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.16.4 Pfizer Products Offered
        7.16.5 Pfizer Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Parkinson's Disease (PD) Drugs Industry Chain Analysis
    8.2 Parkinson's Disease (PD) Drugs Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Parkinson's Disease (PD) Drugs Distributors
    8.3 Parkinson's Disease (PD) Drugs Production Mode & Process
    8.4 Parkinson's Disease (PD) Drugs Sales and Marketing
        8.4.1 Parkinson's Disease (PD) Drugs Sales Channels
        8.4.2 Parkinson's Disease (PD) Drugs Distributors
    8.5 Parkinson's Disease (PD) Drugs Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Parkinson's Disease (PD) Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Parkinson's Disease (PD) Drugs Market Trends
    Table 3. Parkinson's Disease (PD) Drugs Market Drivers
    Table 4. Parkinson's Disease (PD) Drugs Market Challenges
    Table 5. Parkinson's Disease (PD) Drugs Market Restraints
    Table 6. Global Parkinson's Disease (PD) Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Parkinson's Disease (PD) Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Parkinson's Disease (PD) Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Parkinson's Disease (PD) Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Parkinson's Disease (PD) Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Parkinson's Disease (PD) Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Parkinson's Disease (PD) Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Parkinson's Disease (PD) Drugs Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Parkinson's Disease (PD) Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Parkinson's Disease (PD) Drugs Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Parkinson's Disease (PD) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Parkinson's Disease (PD) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease (PD) Drugs as of 2021)
    Table 18. Top Players of Parkinson's Disease (PD) Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Parkinson's Disease (PD) Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Parkinson's Disease (PD) Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Parkinson's Disease (PD) Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Parkinson's Disease (PD) Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Parkinson's Disease (PD) Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Parkinson's Disease (PD) Drugs Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Parkinson's Disease (PD) Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Parkinson's Disease (PD) Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Parkinson's Disease (PD) Drugs Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Parkinson's Disease (PD) Drugs Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Parkinson's Disease (PD) Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Parkinson's Disease (PD) Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Parkinson's Disease (PD) Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Parkinson's Disease (PD) Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Parkinson's Disease (PD) Drugs Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Parkinson's Disease (PD) Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Parkinson's Disease (PD) Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Parkinson's Disease (PD) Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Parkinson's Disease (PD) Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Parkinson's Disease (PD) Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Parkinson's Disease (PD) Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Parkinson's Disease (PD) Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Boehringer Ingelheim Corporation Information
    Table 43. Boehringer Ingelheim Description and Business Overview
    Table 44. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product
    Table 46. Boehringer Ingelheim Recent Development
    Table 47. GlaxoSmithKline Corporation Information
    Table 48. GlaxoSmithKline Description and Business Overview
    Table 49. GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. GlaxoSmithKline Product
    Table 51. GlaxoSmithKline Recent Development
    Table 52. Novartis Corporation Information
    Table 53. Novartis Description and Business Overview
    Table 54. Novartis Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 55. Novartis Product
    Table 56. Novartis Recent Development
    Table 57. Teva Pharmaceutical Industries Corporation Information
    Table 58. Teva Pharmaceutical Industries Description and Business Overview
    Table 59. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 60. Teva Pharmaceutical Industries Product
    Table 61. Teva Pharmaceutical Industries Recent Development
    Table 62. AbbVie Corporation Information
    Table 63. AbbVie Description and Business Overview
    Table 64. AbbVie Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 65. AbbVie Product
    Table 66. AbbVie Recent Development
    Table 67. Abital Pharma Corporation Information
    Table 68. Abital Pharma Description and Business Overview
    Table 69. Abital Pharma Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 70. Abital Pharma Product
    Table 71. Abital Pharma Recent Development
    Table 72. Addex Therapeutics Corporation Information
    Table 73. Addex Therapeutics Description and Business Overview
    Table 74. Addex Therapeutics Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 75. Addex Therapeutics Product
    Table 76. Addex Therapeutics Recent Development
    Table 77. Biogen Corporation Information
    Table 78. Biogen Description and Business Overview
    Table 79. Biogen Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 80. Biogen Product
    Table 81. Biogen Recent Development
    Table 82. Eisai Corporation Information
    Table 83. Eisai Description and Business Overview
    Table 84. Eisai Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 85. Eisai Product
    Table 86. Eisai Recent Development
    Table 87. Eli Lilly Corporation Information
    Table 88. Eli Lilly Description and Business Overview
    Table 89. Eli Lilly Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 90. Eli Lilly Product
    Table 91. Eli Lilly Recent Development
    Table 92. F. Hoffmann-La Roche Corporation Information
    Table 93. F. Hoffmann-La Roche Description and Business Overview
    Table 94. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 95. F. Hoffmann-La Roche Product
    Table 96. F. Hoffmann-La Roche Recent Development
    Table 97. H. Lundbeck Corporation Information
    Table 98. H. Lundbeck Description and Business Overview
    Table 99. H. Lundbeck Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 100. H. Lundbeck Product
    Table 101. H. Lundbeck Recent Development
    Table 102. Impax Laboratories Corporation Information
    Table 103. Impax Laboratories Description and Business Overview
    Table 104. Impax Laboratories Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 105. Impax Laboratories Product
    Table 106. Impax Laboratories Recent Development
    Table 107. Kyowa Hakko Kirin Corporation Information
    Table 108. Kyowa Hakko Kirin Description and Business Overview
    Table 109. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 110. Kyowa Hakko Kirin Product
    Table 111. Kyowa Hakko Kirin Recent Development
    Table 112. Otsuka Pharmaceutical Corporation Information
    Table 113. Otsuka Pharmaceutical Description and Business Overview
    Table 114. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 115. Otsuka Pharmaceutical Product
    Table 116. Otsuka Pharmaceutical Recent Development
    Table 117. Pfizer Corporation Information
    Table 118. Pfizer Description and Business Overview
    Table 119. Pfizer Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 120. Pfizer Product
    Table 121. Pfizer Recent Development
    Table 122. Key Raw Materials Lists
    Table 123. Raw Materials Key Suppliers Lists
    Table 124. Parkinson's Disease (PD) Drugs Customers List
    Table 125. Parkinson's Disease (PD) Drugs Distributors List
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Parkinson's Disease (PD) Drugs Product Picture
    Figure 2. Global Parkinson's Disease (PD) Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Parkinson's Disease (PD) Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Parkinson's Disease (PD) Drugs Sales 2017-2028 (K Pcs)
    Figure 5. United States Parkinson's Disease (PD) Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Parkinson's Disease (PD) Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Parkinson's Disease (PD) Drugs Sales 2017-2028 (K Pcs)
    Figure 8. United States Parkinson's Disease (PD) Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Parkinson's Disease (PD) Drugs Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Parkinson's Disease (PD) Drugs Report Years Considered
    Figure 11. Product Picture of Dopamine Agonist
    Figure 12. Product Picture of Monoamine Oxidase Inhibitors
    Figure 13. Product Picture of Acetylcholinesterase Inhibitors
    Figure 14. Product Picture of Glutamate Inhibitors
    Figure 15. Global Parkinson's Disease (PD) Drugs Market Share by Type in 2022 & 2028
    Figure 16. Global Parkinson's Disease (PD) Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 17. Global Parkinson's Disease (PD) Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 18. Global Parkinson's Disease (PD) Drugs Sales by Type (2017-2028) & (K Pcs)
    Figure 19. Global Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 20. Global Parkinson's Disease (PD) Drugs Price by Type (2017-2028) & (USD/Pcs)
    Figure 21. United States Parkinson's Disease (PD) Drugs Market Share by Type in 2022 & 2028
    Figure 22. United States Parkinson's Disease (PD) Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 23. United States Parkinson's Disease (PD) Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 24. United States Parkinson's Disease (PD) Drugs Sales by Type (2017-2028) & (K Pcs)
    Figure 25. United States Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 26. United States Parkinson's Disease (PD) Drugs Price by Type (2017-2028) & (USD/Pcs)
    Figure 27. Product Picture of Hospital
    Figure 28. Product Picture of Family
    Figure 29. Global Parkinson's Disease (PD) Drugs Market Share by Application in 2022 & 2028
    Figure 30. Global Parkinson's Disease (PD) Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Parkinson's Disease (PD) Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Parkinson's Disease (PD) Drugs Sales by Application (2017-2028) & (K Pcs)
    Figure 33. Global Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Parkinson's Disease (PD) Drugs Price by Application (2017-2028) & (USD/Pcs)
    Figure 35. United States Parkinson's Disease (PD) Drugs Market Share by Application in 2022 & 2028
    Figure 36. United States Parkinson's Disease (PD) Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Parkinson's Disease (PD) Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Parkinson's Disease (PD) Drugs Sales by Application (2017-2028) & (K Pcs)
    Figure 39. United States Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Parkinson's Disease (PD) Drugs Price by Application (2017-2028) & (USD/Pcs)
    Figure 41. North America Parkinson's Disease (PD) Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 42. North America Parkinson's Disease (PD) Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. U.S. Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Parkinson's Disease (PD) Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 46. Europe Parkinson's Disease (PD) Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Parkinson's Disease (PD) Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 53. Asia-Pacific Parkinson's Disease (PD) Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Taiwan Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Philippines Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America Parkinson's Disease (PD) Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 65. Latin America Parkinson's Disease (PD) Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Parkinson's Disease (PD) Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 70. Middle East & Africa Parkinson's Disease (PD) Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. UAE Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Parkinson's Disease (PD) Drugs Value Chain
    Figure 75. Parkinson's Disease (PD) Drugs Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Boehringer Ingelheim
GlaxoSmithKline
Novartis
Teva Pharmaceutical Industries
AbbVie
Abital Pharma
Addex Therapeutics
Biogen
Eisai
Eli Lilly
F. Hoffmann-La Roche
H. Lundbeck
Impax Laboratories
Kyowa Hakko Kirin
Otsuka Pharmaceutical
Pfizer
Frequently Asked Questions
Parkinson's Disease (PD) Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Parkinson's Disease (PD) Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Parkinson's Disease (PD) Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Passenger Vehicle

Passenger Vehicle market is segmented by region (country), players, by Type and by Application. P ... Read More